ARTICLE | Clinical News
EpiStem, Rottapharm S.p.A. preclinical data
September 8, 2008 7:00 AM UTC
In vitro studies of CR 3294, an inducible nitric oxide synthase ( iNOS) and matrix metalloproteinase (MMP) co-inhibitor, showed that it protected small intestinal crypts from cytotoxic insult of comm...